Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients
Authors
Keywords
Tamoxifen, Endocrine therapy, Breast cancer, Circadian variation, Pharmacokinetics
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 152, Issue 1, Pages 119-128
Publisher
Springer Nature
Online
2015-06-06
DOI
10.1007/s10549-015-3452-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer
- (2014) P Saladores et al. PHARMACOGENOMICS JOURNAL
- CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
- (2013) Wendy A. Teft et al. BREAST CANCER RESEARCH AND TREATMENT
- Endocrine Therapy for Advanced/Metastatic Breast Cancer
- (2013) Gaia Schiavon et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Effects of CYP Induction by Rifampicin on Tamoxifen Exposure
- (2012) L Binkhorst et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evidence for Therapeutic Drug Monitoring of Targeted Anticancer Therapies
- (2012) Bo Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients
- (2012) James M. Rae et al. JNCI-Journal of the National Cancer Institute
- Clinical and biomarker predictors of side effects from tamoxifen
- (2011) Wendy Lorizio et al. BREAST CANCER RESEARCH AND TREATMENT
- Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma
- (2011) T E Mürdter et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes
- (2011) L Madlensky et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry
- (2011) Lisette Binkhorst et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Molecular Basis of Chronopharmaceutics
- (2011) Shigehiro Ohdo et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- CYP2D6 Inhibition and Breast Cancer Recurrence in a Population-Based Study in Denmark
- (2011) T. L. Lash et al. JNCI-Journal of the National Cancer Institute
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Circadian Expression Profiles of Drug-Processing Genes and Transcription Factors in Mouse Liver
- (2008) Y.-K. J. Zhang et al. DRUG METABOLISM AND DISPOSITION
- The influence of circadian rhythms on the kinetics of drugs in humans
- (2008) Massimo Baraldo Expert Opinion on Drug Metabolism & Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now